[1. Le C, Bedocs PM. Disseminated superficial actinic porokeratosis [Internet]. Treasure Island (FL): StatPe arls Publishing; 2019 [cited 2020 Feb 21]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK 459 202/.]Search in Google Scholar
[2. Kanitakis J. Porokeratoses: an update of clinical, aetiopathogenic and therapeutic features. Eur J Dermatol. 2014;24(5):533-44.10.1684/ejd.2014.240225115203]Search in Google Scholar
[3. Judge MR, McLean WHI, Munro CS. Disorders of keratinization. In: Burns T, Breathnach S, Cox N, Griffiths C, editors. Rook’s textbook of dermatology. 6th ed. Oxford: Blackwell Publishing Ltd; 2010. p. 19.1-121.10.1002/9781444317633.ch19]Search in Google Scholar
[4. Al-Haseni A, Chitgopeker P, Ho JD, Goldberg LJ, Sahni D. Amelanotic melanoma arising within a lesion of disseminated superficial actinic porokeratosis: an unusual presentation leading to a novel therapeutic approach. Dermatol Ther. 2018;31(1):e12552.10.1111/dth.1255228976625]Search in Google Scholar
[5. Sertznig P, von Felbert V, Megahed M. Porokeratosis: present concepts. J Eur Acad Dermatol Venereol. 2012;26(4):404-12.10.1111/j.1468-3083.2011.04275.x21929548]Search in Google Scholar
[6. Jin R, Luo X, Luan K, Liu L, Sun LD, Yang S, et al. Disorder of the mevalonate pathway inhibits calcium-induced differentiation of keratinocytes. Mol Med Rep. 2017;16(4):4811-6.10.3892/mmr.2017.712828765912]Search in Google Scholar
[7. Stepanović M, Paravina M, Marković D, Janjić Spasić D. Progressive disseminated superficial actinic porokeratosis: a case report with a family history in three generations. Serbian Journal of Dermatology and Venereology. 2013;5(3):131-40.10.2478/sjdv-2013-0011]Search in Google Scholar
[8. Thomaidou E, Katz M, Leibovici V. Two cases of disseminated superficial actinic porokeratosis (DSAP) and treatment literature review. Our Dermatology Online. 2018;9(3):241-8.10.7241/ourd.20183.3]Search in Google Scholar
[9. Uusküla A, Erm T. Disseminated giant hyperkeratotic porokeratosis and treatment with acitretin: a case report. Acta Derm Venereol. 2015;95(2):241-2.10.2340/00015555-190824923352]Search in Google Scholar
[10. Li X, Zhou Q, Zhu L, Zhao Z, Wang P, Zhang L, et al. Analysis of clinical and genetic features of nine patients with disseminated superfacial actinic porokeratosis. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2017;34 (4):481-5.]Search in Google Scholar
[11. Calonje E. Histopathology of the skin: general principles. In: Burns T, Breathnach S, Cox N, Griffiths C, editors. Rook’s textbook of dermatology. 6th ed. Oxford: Blackwell Publishing Ltd; 2010. p. 10.1-43.10.1002/9781444317633.ch10]Search in Google Scholar
[12. Khaled A, Kourda M, Abdelmoula, M’ssedi L, Tougourti MN, Kamoun MR. Late-onset disseminated superficial actinic porokeratosis in an elderly woman. Dermatol Ther (Heidelb). 2011;1(1):15-9.10.1007/s13555-011-0004-0343764022984659]Search in Google Scholar
[13. Patrizi A, D’Acunto C, Passarini B, Neri I. Porokeratosis in the elderly: a new subtype of disseminated superficial actinic porokeratosis. Acta Derm Venerol. 2000;80(4):302-4.10.1080/00015550075001224311028869]Search in Google Scholar
[14. Nicola A, Magliano J. Dermoscopy of disseminated superficial actinic porokeratosis. Actas Dermosifiliogr. 2017;108(5):e33-7.10.1016/j.ad.2015.09.02527015657]Search in Google Scholar
[15. Stojanović S, Jovanović M, Vučković N, Ivkov-Simić M, Tasić S. Linear porokeratosis: a case report. Serbian Journal of Dermatology and Venereology. 2012;4(3): 105-12.10.2478/v10249-012-0009-4]Search in Google Scholar
[16. Aird GA, Sitenga JL, Nguyen AH, Vaudreuil A, Huerter CJ. Light and laser treatment modalities for disseminated superficial actinic porokeratosis: a systematic review. Lasers Med Sci. 2017;32(4):945-52.10.1007/s10103-017-2179-928239750]Search in Google Scholar
[17. Ross NA, Rosenbaum LE, Saedi N, Arndt KA, Dover JS. Disseminated superficial actinic porokeratosis improved with fractional 1927-nm laser treatments. J Cosmet Laser Ther. 2016;18(1):53-5.10.3109/14764172.2015.106365726820042]Search in Google Scholar
[18. Ramelyte E, Bylaite-Bucinskiene M, Dummer R, Imhof L. Successful use of grenz rays for disseminated superficial actinic porokeratosis: report of 8 cases. Dermatology. 2017;233(2-3):217-22.10.1159/00047885528817832]Search in Google Scholar
[19. Park BJ, Oh EH, Kim JE, Ko JY, Ro YS. Treatment of disseminated superficial actinic porokeratosis with oral alitretinoin. J Eur Acad Dermatol Venereol. 2017;31(11):e505-7.10.1111/jdv.1435428543730]Search in Google Scholar
[20. Weidner T, Illing T, Miguel D, Elsner P. Treatment of porokeratosis: a systematic review. Am J Clin Dermatol. 2017;18(4):435-49.10.1007/s40257-017-0271-328283894]Search in Google Scholar
[21. Atzmony L, Lim YH, Hamilton C, Leventhal JS, Wagner A, Paller AS, et al. Topical cholesterol/lovastatin for the treatment of porokeratosis: a pathogenesis-directed therapy. J Am Acad Dermatol. 2020;82 (1):123-31.10.1016/j.jaad.2019.08.043703969831449901]Search in Google Scholar
[22. Shoimer I, Robertson LH, Storwick G, Haber RM. Eruptive disseminated porokeratosis: a new classification system. J Am Acad Dermatol. 2014;71(2):398-400.10.1016/j.jaad.2014.04.03425037793]Search in Google Scholar